Companies /Basic Materials

Avient Corp

NYSE: AVNT Specialty Chemicals
$40.58
▼ $0.35 (−0.86%) today
Markets open · 1:33pm ET

Q1 2025 Earnings

Reported May 6, 2025, 6:02am ET · SEC source
$0.76
Beat +0.48%
EPS · est. $0.76
$826.6M
Miss −0.23%
Revenue · est. $828.5M
−2.8%
Trailing market
AVNT vs S&P since report
5 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+2%+4%May 6May 7report 6:02am ETearnings+0.2%+4.6%
0+2%+4%May 6May 7earnings+0.2%+4.6%
AVNT +4.6%S&P 500 +0.2%
0+2%+4%May 6May 7report 6:02am ETearnings+0.1%+4.6%
0+2%+4%May 6May 7earnings+0.1%+4.6%
AVNT +4.6%NASDAQ +0.1%
0+5%+10%+15%May 5May 13report 6:02am ETearnings+4.8%+11.8%
0+5%+10%+15%May 5May 13earnings+4.8%+11.8%
AVNT +11.8%S&P 500 +4.8%
0+5%+10%+15%May 5May 13report 6:02am ETearnings+7.0%+11.8%
0+5%+10%+15%May 5May 13earnings+7.0%+11.8%
AVNT +11.8%NASDAQ +7.0%
+4.32%
Day of report
+1.83%
Next session
+9.36%
One week
+4.43%
30 days

S&P 500 over the same 30 days: +7.22%.

Did AVNT Beat Earnings? Q1 2025 Results

Avient Corporation delivered a largely in-line first quarter for 2025, posting adjusted EPS of $0.76 against a consensus estimate of $0.7564 — a modest beat of 0.48% — while revenue of $826.60 million came in fractionally light, missing the $828.52 million estimate by 0.23% and slipping 0.3% year-over-year. The headline numbers, however, obscure a more turbulent quarter beneath the surface: an $86.30 million impairment charge tied to the company's decision to abandon its S/4HANA cloud ERP initiative drove GAAP EPS to a loss of $0.22, compared to a profit of $0.54 in the year-ago period. Strip out the noise, and adjusted EBITDA edged up to $144.70 million from $143.10 million, with margins expanding 20 basis points to 17.5%. Geographic performance was uneven — Asia and Latin America surged with 9% and 17% organic growth respectively, while U.S. and Canada softened 3% amid weakening consumer sentiment. Management maintained its full-year adjusted EPS guidance of $2.70 to $2.94 and guided Q2 adjusted EPS to $0.79, citing its local-for-local manufacturing model as a buffer against tariff uncertainty, and separately announced CEO Ashish Khandpur's elevation to board chairman.

Key Takeaways
  • Organic sales growth of 2% excluding foreign exchange impact
  • Adjusted EBITDA margin expansion of 20 basis points to 17.5%
  • Strong organic sales growth in Asia (9%) and Latin America (17%)
  • Fourth consecutive quarter of organic sales growth
  • Cost control and streamlined organizational structure
  • EMEA delivered fourth consecutive quarter of growth with 2% organic sales increase

“I'm pleased with our team's execution this quarter to deliver these results in a volatile and changing macro-economic backdrop.”

Avient CEO, on the earnings call

Forward Guidance & Outlook

Avient maintained its full-year 2025 guidance with adjusted EBITDA of $540 to $570 million and adjusted EPS of $2.70 to $2.94. For Q2 2025, the company expects adjusted EPS of $0.79, representing 4% growth over the prior year quarter. Management anticipates weakness in consumer and transportation end markets but sees opportunities for growth in packaging, defense, and healthcare. The full-year outlook is described as less certain and highly dependent on global economic growth. The company intends to pay down $100 to $200 million of debt by year-end. Management expects minimal direct impact from tariffs due to its local-for-local sourcing and manufacturing model.

AVNT YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$300.0M$600.0M$900.0M$829.0M$826.6MRevenue$278.2M$263.2MGross Profit$94.6M$700,000Operating Income
$0$300.0M$600.0M$900.0MRevenueGross ProfitOperating Income

AVNT Revenue by Segment

Color, Additives and Inks$519.7M
Specialty Engineered Materials$308.4M

Figures from SEC filings and company reports. Not investment advice.